Opioid Use Disorder Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Braeburn Pharmaceuticals, BioXcel Therapeutics, Braeburn Pharmaceuticals, Alkermes, Inc., Indivior Inc.

The Opioid Use Disorder market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Opioid Use Disorder pipeline products will significantly revolutionize the Opioid Use Disorder market dynamics.
DelveInsight's "Opioid Use Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Opioid Use Disorder, historical and forecasted epidemiology as well as the Opioid Use Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Opioid Use Disorder market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Opioid Use Disorder Market Forecast
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Opioid Use Disorder Market Report:
• The Opioid Use Disorder market size was valued approximately USD 2000 Million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In June 2024, Indivior has administered the first dose to a participant in a Phase II clinical trial of INDV-2000 for individuals suffering from opioid use disorder (OUD). This double-blind, placebo-controlled, randomized, dose-ranging study is designed to assess the safety and efficacy of the treatment over a three-month duration in participants with moderate to severe OUD who are seeking treatment.
• In 2023, the United States held the largest market share for Opioid Use Disorder (OUD), reaching approximately USD 1.4 billion, compared to the EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
• In 2023, the United States held the largest market share for Opioid Use Disorder (OUD) among the 7MM, representing around 67% of the total market.
• The total market size for Opioid Use Disorder (OUD) in the EU4 and the UK exceeded USD 500 million in 2023.
• According to DelveInsight's estimates, the total number of individuals with Opioid Use Disorder (OUD) in the US exceeded 2.1 million in 2023.
• Opioid Use Disorder (OUD) was more prevalent in males than in females across the 7MM.
• The majority of Opioid Use Disorder (OUD) cases occur in the 18 to 25 age group, with a significant number also found in individuals aged 26 and older.
• In 2023, the prevalent population of Opioid Use Disorder (OUD) in the EU4 and the UK was approximately 1.44 million cases, with Germany reporting the highest number of cases.
• Key Opioid Use Disorder Companies: Braeburn Pharmaceuticals, Indivior, BioXcel Therapeutics, Alkermes, Inc., Indivior Inc., Evon Medics LLC, and others
• Key Opioid Use Disorder Therapies: BRIXADI (buprenorphine), SUBLOCADE (buprenorphine), CAM2038, BXCL501, CAM2038, NTX/BUP, SUBOXONE, CAM2038, CBOT + TAU, and others
• The Opioid Use Disorder market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Opioid Use Disorder pipeline products will significantly revolutionize the Opioid Use Disorder market dynamics.

Opioid Use Disorder Overview
Opioid use disorder is the chronic use of opioids that causes clinically significant distress or impairment. Opioid use disorder consists of an overpowering desire to use opioids, increased opioid tolerance, and withdrawal syndrome when discontinued.

Get a Free sample for the Opioid Use Disorder Market Report -
https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Opioid Use Disorder Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Opioid Use Disorder Epidemiology Segmentation:
The Opioid Use Disorder market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Opioid Use Disorder
• Prevalent Cases of Opioid Use Disorder by severity
• Gender-specific Prevalence of Opioid Use Disorder
• Diagnosed Cases of Episodic and Chronic Opioid Use Disorder

Download the report to understand which factors are driving Opioid Use Disorder epidemiology trends @ Opioid Use Disorder Epidemiology Forecast
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Opioid Use Disorder Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Opioid Use Disorder market or expected to get launched during the study period. The analysis covers Opioid Use Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Opioid Use Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Opioid Use Disorder Therapies and Key Companies
• BRIXADI (buprenorphine): Braeburn Pharmaceuticals
• SUBLOCADE (buprenorphine): Indivior
• CAM2038: Braeburn Pharmaceuticals
• BXCL501: BioXcel Therapeutics
• CAM2038: Braeburn Pharmaceuticals

Discover more about therapies set to grab major Opioid Use Disorder market share @ Opioid Use Disorder Treatment Market
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Opioid Use Disorder Market Strengths
• After the US recognized its opioid crisis and addressed it, there has been a surge in awareness and overall funding for research and development regarding opioid use disorder
• Although there have been only a few active ingredients proven to be effective in the treatment of OUD, their different and innovative formulations have revolutionized the treatment landscape by significantly improving treatment adherence among patients and preventing relapses

Opioid Use Disorder Market Opportunities
• Removal of the DATA 2000 waiver and cap on how many patients can be treated with buprenorphine by a physician is set to transform the treatment landscape of OUD in the US, further increasing the usage of buprenorphine in the treatment setting
• Upcoming policy changes are expected to further improve access to MOUD for OUD patients and improve their usage in the treatment setting

Scope of the Opioid Use Disorder Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Opioid Use Disorder Companies: Braeburn Pharmaceuticals, Indivior, BioXcel Therapeutics, Alkermes, Inc., Indivior Inc., Evon Medics LLC, and others
• Key Opioid Use Disorder Therapies: BRIXADI (buprenorphine), SUBLOCADE (buprenorphine), CAM2038, BXCL501, CAM2038, NTX/BUP, SUBOXONE, CAM2038, CBOT + TAU, and others
• Opioid Use Disorder Therapeutic Assessment: Opioid Use Disorder current marketed and Opioid Use Disorder emerging therapies
• Opioid Use Disorder Market Dynamics: Opioid Use Disorder market drivers and Opioid Use Disorder market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Opioid Use Disorder Unmet Needs, KOL's views, Analyst's views, Opioid Use Disorder Market Access and Reimbursement

To know more about Opioid Use Disorder companies working in the treatment market, visit @ Opioid Use Disorder Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Opioid Use Disorder Market Report Introduction
2. Executive Summary for Opioid Use Disorder
3. SWOT analysis of Opioid Use Disorder
4. Opioid Use Disorder Patient Share (%) Overview at a Glance
5. Opioid Use Disorder Market Overview at a Glance
6. Opioid Use Disorder Disease Background and Overview
7. Opioid Use Disorder Epidemiology and Patient Population
8. Country-Specific Patient Population of Opioid Use Disorder
9. Opioid Use Disorder Current Treatment and Medical Practices
10. Opioid Use Disorder Unmet Needs
11. Opioid Use Disorder Emerging Therapies
12. Opioid Use Disorder Market Outlook
13. Country-Wise Opioid Use Disorder Market Analysis (2020-2034)
14. Opioid Use Disorder Market Access and Reimbursement of Therapies
15. Opioid Use Disorder Market Drivers
16. Opioid Use Disorder Market Barriers
17. Opioid Use Disorder Appendix
18. Opioid Use Disorder Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Opioid Use Disorder Epidemiology https://www.delveinsight.com/report-store/opioid-use-disorder-oud-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Opioid Use Disorder Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Opioid Use Disorder epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market
https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
DelveInsight's "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), historical and forecasted epidemiology as well as the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Congestive Heart Failure Market
https://www.delveinsight.com/report-store/congestive-heart-failure-market
DelveInsight's "Congestive Heart Failure Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of CHF, historical and forecasted epidemiology as well as the CHF market trends in the United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan.

CDMO Market
https://www.delveinsight.com/report-store/contract-development-manufacturing-organization-market
Global CDMO market was valued at USD 100.02 billion in 2021, growing at a CAGR of 6.25% during the forecast period from 2024 to 2030, in order to reach USD 143.87 billion by 2030. Factors such as rising prevalence of various chronic and acute diseases leading to growing requirement of drugs, rising popularity of biologics as a treatment option are further expected to drive the demand for services offered by CDMOs as biologics being more complex than small molecules require elaborate facilities for product development.

Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market
DelveInsight's "Duchenne Muscular Dystrophy Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Duchenne Muscular Dystrophy historical and forecasted epidemiology as well as the Duchenne Muscular Dystrophy market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.